Commentary on Unexpected Increased Platelet Count in an Acute Myeloid Leukemia Patient
Clin Chem. 2025 Jul 4;71(7):740-741. doi: 10.1093/clinchem/hvaf010. NO ABSTRACT PMID:40613797 | DOI:10.1093/clinchem/hvaf010
ccinfoadmin
Pulse Oximeter Performance across Populations with Diverse Skin Tones
Clin Chem. 2025 Jul 4;71(7):826-827. doi: 10.1093/clinchem/hvaf052. NO ABSTRACT PMID:40613794 | DOI:10.1093/clinchem/hvaf052
Commentary on Unexpected Increased Platelet Count in an Acute Myeloid Leukemia Patient
Clin Chem. 2025 Jul 4;71(7):741-742. doi: 10.1093/clinchem/hvaf036. NO ABSTRACT PMID:40613796 | DOI:10.1093/clinchem/hvaf036
Congenital Disorder of Glycosylation in a 40-Year-Old Male with Hypogammaglobulinemia
Clin Chem. 2025 Jul 4;71(7):821-823. doi: 10.1093/clinchem/hvaf048. NO ABSTRACT PMID:40613798 | DOI:10.1093/clinchem/hvaf048
Unexpected Increased Platelet Count in an Acute Myeloid Leukemia Patient
Clin Chem. 2025 Jul 4;71(7):737-740. doi: 10.1093/clinchem/hvae223. NO ABSTRACT PMID:40613799 | DOI:10.1093/clinchem/hvae223
Polygenic Effects on Hb A1c May Mask Hyperglycemia and Increase Retinopathy Risk
Clin Chem. 2025 Jul 4;71(7):824-825. doi: 10.1093/clinchem/hvaf040. NO ABSTRACT PMID:40613795 | DOI:10.1093/clinchem/hvaf040
Acoustophoresis-based blood sampling and plasma separation for potentially minimizing sampling-related blood lossAmal Nathon July 4, 2025 at 10:00 am
Clin Chem Lab Med. 2025 Jul 7. doi: 10.1515/cclm-2025-0539. Online ahead of print. ABSTRACT OBJECTIVES: Frequent blood sampling in vulnerable patient groups, such as prematurely born infants, can lead to significant blood loss and increased transfusion needs. Current pre-analytical technology requires comparably large blood volumes and leads to discarding of cells. This study investigates a … Read more
Correction to: Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation
Clin Chem. 2025 Jul 2:hvaf075. doi: 10.1093/clinchem/hvaf075. Online ahead of print. NO ABSTRACT PMID:40601566 | DOI:10.1093/clinchem/hvaf075
Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2V617F mutated myeloproliferative disordersChristoph Winkleron July 2, 2025 at 10:00 am
Clin Chem Lab Med. 2025 Jul 3. doi: 10.1515/cclm-2025-0306. Online ahead of print. ABSTRACT OBJECTIVES: The acquired, somatic JAK2V617F mutation is the most common molecular aberration in patients with myeloproliferative neoplasms (MPN) and also significantly involved in the regulation of T cell immunity. PD-1, PD-L1 and CTLA-4 are key immune checkpoint regulators that are elevated … Read more